NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A trial of six men over an arson attack at an east London business that supported Ukraine’s war effort against Russia has begun, with prosecutors arguing that the evidence against them was “overwhelming.”Read More